https://www.selleckchem.com/products/pcna-i1.html
In this study, we aimed to investigate the prognostic value of metabolic F-fluorodeoxyglucose positron emission tomography/computed tomography parameters in malignant pleural mesothelioma patients. A total of 65 patients with malignant pleural mesothelioma (34 males, 31 females; median age 60 years; range, 39 to 84 years) who underwent whole-body F-fluorodeoxyglucose positron emission tomography/computed tomography for staging before treatment between March 2008 and January 2018 were included. Relationships between clinicopathological f
Like
Comment
Share
